134 related articles for article (PubMed ID: 28029084)
1. Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene.
Tanoue C; Sugihara K; Tayama Y; Uramaru N; Watanabe Y; Ohta S; Kitamura S
Drug Metab Lett; 2017; 10(4):278-285. PubMed ID: 28029084
[TBL] [Abstract][Full Text] [Related]
2. Strain difference of oxidative metabolism of the sedative-hypnotic zaleplon by aldehyde oxidase and cytochrome P450 in vivo and in vitro in rats.
Tanoue C; Sugihara K; Uramaru N; Watanabe Y; Tayama Y; Ohta S; Kitamura S
Drug Metab Pharmacokinet; 2013; 28(3):269-73. PubMed ID: 23358259
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.
Lake BG; Ball SE; Kao J; Renwick AB; Price RJ; Scatina JA
Xenobiotica; 2002 Oct; 32(10):835-47. PubMed ID: 12419014
[TBL] [Abstract][Full Text] [Related]
4. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats.
Kawashima K; Hosoi K; Naruke T; Shiba T; Kitamura M; Watabe T
Drug Metab Dispos; 1999 Mar; 27(3):422-8. PubMed ID: 10064576
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices.
Renwick AB; Ball SE; Tredger JM; Price RJ; Walters DG; Kao J; Scatina JA; Lake BG
Xenobiotica; 2002 Oct; 32(10):849-62. PubMed ID: 12419015
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
[TBL] [Abstract][Full Text] [Related]
8. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
Klecker RW; Cysyk RL; Collins JM
Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of human liver aldehyde oxidase by raloxifene.
Obach RS
Drug Metab Dispos; 2004 Jan; 32(1):89-97. PubMed ID: 14709625
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases.
Weidert ER; Schoenborn SO; Cantu-Medellin N; Choughule KV; Jones JP; Kelley EE
Nitric Oxide; 2014 Feb; 37():41-5. PubMed ID: 24406683
[TBL] [Abstract][Full Text] [Related]
11. Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.
Adusumalli S; Jamwal R; Obach RS; Ryder TF; Leggio L; Akhlaghi F
Drug Metab Dispos; 2019 Aug; 47(8):874-882. PubMed ID: 31182423
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of aldehyde oxidase in Donryu rats.
Itoh K; Masubuchi A; Sasaki T; Adachi M; Watanabe N; Nagata K; Yamazoe Y; Hiratsuka M; Mizugaki M; Tanaka Y
Drug Metab Dispos; 2007 May; 35(5):734-9. PubMed ID: 17293383
[TBL] [Abstract][Full Text] [Related]
13. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Strelevitz TJ; Orozco CC; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
[TBL] [Abstract][Full Text] [Related]
14. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
Heydorn WE
Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
[TBL] [Abstract][Full Text] [Related]
15. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
Sugihara K; Kitamura S; Tatsumi K
Drug Metab Dispos; 1996 Feb; 24(2):199-202. PubMed ID: 8742231
[TBL] [Abstract][Full Text] [Related]
16. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.
Itoh K; Yamamura M; Takasaki W; Sasaki T; Masubuchi A; Tanaka Y
Biopharm Drug Dispos; 2006 Apr; 27(3):133-9. PubMed ID: 16400710
[TBL] [Abstract][Full Text] [Related]
17. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Zientek M; Jiang Y; Youdim K; Obach RS
Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
[TBL] [Abstract][Full Text] [Related]
18. Rat strain differences in stereospecific 2-oxidation of RS-8359, a reversible and selective MAO-A inhibitor, by aldehyde oxidase.
Sasaki T; Masubuchi A; Yamamura M; Watanabe N; Hiratsuka M; Mizugaki M; Itoh K; Tanaka Y
Biopharm Drug Dispos; 2006 Jul; 27(5):247-55. PubMed ID: 16586463
[TBL] [Abstract][Full Text] [Related]
19. Identification of enzymes responsible for nitrazepam metabolism and toxicity in human.
Konishi K; Fukami T; Gotoh S; Nakajima M
Biochem Pharmacol; 2017 Sep; 140():150-160. PubMed ID: 28606603
[TBL] [Abstract][Full Text] [Related]
20. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
